Identification of Brucella abortus genes in elk (Cervus elaphus) using in vivo-induced antigen technology (IVIAT) reveals novel markers of infection

Veterinary Microbiology

Volumn 142, Issue 3-4, 2010, Pages 367-372

  Lowry, J E ^a   Goodridge, L ^a   Vernati, G ^a   Fluegel, A M ^a   Edwards, W H ^b   Andrews, G P ^a  

^a UNIVERSITY OF WYOMING   (United States)

^b Wyoming Fish and Game   (United States)

Author keywords

Brucellosis; Host pathogen interaction; IVIAT

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL DNA; BACTERIUM ANTIBODY; CARRIER PROTEIN; MALATE DEHYDROGENASE; OUTER MEMBRANE PROTEIN;

ANTIGEN DETECTION; ARTICLE; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIUM CULTURE; BLOOD SAMPLING; BRUCELLA ABORTUS; BRUCELLOSIS; CATTLE; CONTROLLED STUDY; CROSS REACTION; DISEASE MARKER; DOMESTIC ANIMAL; ESCHERICHIA COLI; GENE IDENTIFICATION; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; IMMUNOBLOTTING; IMMUNOREACTIVITY; IN VITRO STUDY; LIVESTOCK; MOLECULAR CLONING; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PROTEIN EXPRESSION; PROTEIN SECRETION; RED DEER; WESTERN BLOTTING; WILD ANIMAL; ZOONOSIS;

ANIMALS; ANTIGENS, BACTERIAL; BIOLOGICAL MARKERS; BLOTTING, WESTERN; BRUCELLA ABORTUS; BRUCELLOSIS; CROSS REACTIONS; DEER; GENES, BACTERIAL; IMMUNOLOGIC TECHNIQUES; WYOMING;

ANIMALIA; BOS; BRUCELLA MELITENSIS BIOVAR ABORTUS; CERVUS ELAPHUS;

EID: 77952089938     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2009.10.010     Document Type: Article

References (30)

1. Al Dahouk S., Tomaso H., Nockler K., Neubauer H. The detection of Brucella spp. using PCR-ELISA and real-time PCR assays. Clin. Lab. 2004, 50:387-394.
2. Anderson, E.S., Paulley, J.T., Gaines, J.M., Valderas, M.W., Martin, D.W., Menscher, E., Brown, T.D., Burns, C.S. Roop II, R.M., 2009. The manganese transporter MntH is a critical virulence determinant for Brucella abortus 2308 in experimentally infected mice. Infect. Immun. (Epup ahead of print on 1 June 2009).
3. Biagini R.E., Sammons D.L., Smith J.P., MacKenzie B.A., Striley C.A., Snawder J.E., Robertson S.A., Quinn C.P. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin g in serum and whole blood. Clin. Vac. Immunol. 2006, 13(5):541-546.
4. Caro-Hernandez P., Fernandez-Lago L., de Miguel M.J., Martin-Martin A.I., Cloeckaert A., Grillo M.J., Vizcaino N. Role of the Omp25/Omp31 family in outer membrane properties and virulence of Brucella ovis. Infect. Immun. 2007, 75(8):4050-4061.
5. Chang B., Kura F., Amemura-Maekawa J., Koizumi N., Watanabe H. Identification of a novel adhesion molecule involved in the virulence of Legionella pneumophila. Infect. Immun. 2005, 73(7):4272-4280.
6. Chirhart-Gilleland R.L., Kovach M.E., Elzer P.H., Jennings S.R., Roop R.M. Identification and characterization of a 14-kilodalton Brucella abortus protein reactive with antibodies from naturally and experimentally infected hosts and T lymphocytes from experimentally infected BALB/c mice. Infect. Immun. 1998, 66(8):4000-4003.
7. Comerci D.J., Martinez-Lorenzo M.J., Sieira R., Gorvel J.P., Ugalde R.A. Essential role of the VirB machinery in the maturation of the Brucella abortus containing vacuole. Cell Microbiol. 2001, 3:159-168.
8. Deb D.K., Dahiya P., Srivastava K.K., Srivastava R., Srivastava B.S. Selective identification of new therapeutic targets of Mycobacterium tuberculosis by IVIAT approach. Tuberculosis 2002, 82:175-182.
9. Gall D., Nielson K., Forbes L., Cook W., Leclair D., Balsevicius S., Kelly L., Smith P., Mallory M. Evaluation of the fluorescence polarization assay and comparison to other serological assays for detection of brucellosis in cervids. J. Wildl. Dis. 2001, 37:110-118.
10. Gardy J.L., Laird M.R., Chen F., Rey S., Walsh C.J., Ester M., Brinkman F.S.L. PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and insights gained from comparative proteome analysis. Bioinformatics 2005, 21(5):617-623.
11. Godfroid J. Brucellosis in wildlife. Rev. Sci. Technol. Off. Int. Epiz. 2002, 21:277-286.
12. Handfield M., Brady L.J., Progulske-Fox A., Hillman J.D. IVIAT: a novel method to identify microbial genes expressed specifically during human infections. Trends Microbiol. 2000, 8:336-339.
13. Hong P.C., Tsolis R.M., Ficht T.A. Identification of genes required for chronic persistence of Brucella abortus in mice. Infect. Immun. 2000, 68:4102-4107.
14. Ko J., Splitter G.A. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin. Microbiol. Rev. 2003, 16(1):65-78.
15. Liu D., Cole R.B., Reeves P.R. An O-antigen processing function for WzX (RfbX) a promising candidate for O-unit flippase. J. Bacteriol. 1996, 178(7):2102-2107.
16. Manning D.S., Reschke D.K., Judd R.C. Omp85 proteins of Neisseria gonorrhoeae and Neisseria meningitidis are similar to Haemophilus influenzae D-15-Ag and Pasteurella multocida Oma87. Microb. Pathog. 1998, 25(1):11-21.
17. Miranda R.L., Conway T., Leatham M.P., Chang D.E., Norris W.E., Allen J.H., Stevenson S.J., Laux D.C., Cohen P.S. Glycolytic and gluconeogenic growth of Escherichia coli O157:H7 (EDL933) and E. coli K-12 (MG1655) in the mouse intestine. Infect. Immun. 2004, 72:1666-1676.
18. Navarro E., Caseo M.A., Solera J. Diagnosis of human brucellosis using PCR. Exp. Rev. Mol. Diag. 2004, 4:115-123.
19. Robert V., Volokhina E.B., Senf F., Bos M.P., Van Gelder P., Tommassen J. Assembly factor Omp85 recognizes its outer membrane protein substrates by a species-specific C-Terminal motif. PLoS Biol. 2006, 4(11):e377.
20. Rollins, et al. In vivo induced antigen technology (IVIAT). Cell. Microbiol. 2005, 7:1-9.
21. Rollins S.M., Peppercorn A., Young J.S., Drysdale M., Baresch A., Bikowski M., Ashford D.A., Quinn C.P., Handfield M., Hillman J.D., Lyons C.R., Koehler T.M., Calderwood S.B., Ryan E.T. Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis. PLoS One 2008, 3(3):e1824.
22. Roux C.M., Rolán H.G., Santos R.L., Beremand P.D., Thomas T.L., Adams G.L., Tsolis R.M. Brucella requires a functional Type IV secretion system to elicit innate immune responses in mice. Cell Microbiol. 2007, 9(7):1851-1869.
23. Saegerman C., De Waele L., Gilson D., Godfroid J., Thiange P., Michel P., Limbourg B., Vo T.K., Limit J., Letesson J.J., Berkvens D. Evaluation of three i-ELISAs using monoclonal antibodies and protein G as peroxidase conjugate for the diagnosis of bovine brucellosis. Vet. Microbiol. 2004, 100(1-2):91-105.
24. Schurig G.G., Roop R.M., Bagchi T., Boyle S., Buhrman D., Sriranganathan N. Biological properties of RB51: a stable rough strain of Brucella abortus. Vet. Microbiol. 1991, 28:171-188.
25. Tang D.J., He Y.Q., Feng J.X., He B.R., Jiang B.L., Lu G.T., Chen B., Tang J.L. Xanthomonas campestris pv. campestris possesses a single gluconeogenic pathway that is required for virulence. J. Bacteriol. 2005, 187(17):6231-6237.
26. United States Department of Agriculture (USDA), 2003. Brucellosis in Cervidae:Uniform Methods and Rules. September 30, 2003.
27. Van Houten C.K., Belden E.L., Kreeger T.J., Williams E.S., Edwards W.H., Thorne E.T., Cook W.E., Mills K.W. Validation of a Brucella Abortus competitive enzyme-linked immunosorbent assay for use in Rocky Mountain Elk (Cervus Elaphus Nelson). J. Wildl. Dis. 2003, 39:316-322.
28. Vemulapalli R., He Y., Buccolo L.S., Boyle S.M., Sriranganathan N., Schurig G.G. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation. Infect. Immun. 2000, 68(7):3927-3932.
29. Vines E.D., Marolda C.L., Balachandran A., Valvano M.A. Defective O-antigen polymerization in tolA and pal mutants of Escherichia coli in response to extracytoplasmic stress. J. Bacteriol. 2005, 187(10):3359-3368.
30. Zygmunt M.S., Hagius S.D., Walker J.V., Elzer P.H. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host. Microb. Infect. 2006, 8:2849-2854.